glp 1 and gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica The dual glucose-dependent insulinotropic polypeptide

Supports a gut environment where GLP-1 thrives*: Eriomin and Feiolix promote a healthy metabolic environment by supporting gut health and maintaining balanced oxidative stress and inflammation responses.

This includes integrating the latest clinical trial data and delving into potential signaling pathways and pharmacological mechanisms

Covers SURPASS/SURMOUNT trials, dosing, and semaglutide comparison.

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.

This product does not contain synthetic GLP-1 and is not a GLP-1 agonist drug